A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
A phase 2 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 103 participants.
Also called NCT05884866
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 2
- Enrolled
- 103 participants
- Sponsor
- Klinikum Nürnberg
- Registry
-
NCT05884866 -
2022-002721-99
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Germany
- Registry status
- Completed
Technical summary
Registry record NCT05884866. Randomized; quadruple masking; primary purpose treatment. Start 2023-07-13 (actual); primary completion 2025-12-29 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- A Study to Investigate the Mechanistic Effects of Dapagliflozin Alone or in Combination With Balcinrenone, Compared to Balcinrenone and Placebo on Body Fluid and Electrolyte Handling and Energy Metabolism in Participants Over 50 Years of Age With Chronic Kidney Disease.
- Acronym
- DapaBalci-Leap
- Condition
- Chronic Renal Failure
- Condition
- Mechanistic Effects of SGLT2 Inhibition and/ or MR Antagonism on Body Fluid and Electrolyte Homeostatis
- Condition
- Chronic Kidney Disease Stage 3
- Condition
- Electrolyte and Fluid Balance Conditions
- Intervention (Drug)
- Dapagliflozin 10mg Tab
- Intervention (Drug)
- Balcinrenone 50mg Capsule
- Intervention (Drug)
- Balcinrenone 100mg Capsule
- Intervention (Drug)
- Dapagliflozin matching Placebo
- Intervention (Drug)
- Balcinrenone 50mg matching Placebo
- Intervention (Drug)
- Balcinrenone 100mg matching Placebo
- Lead sponsor
- Klinikum Nürnberg
Record details
- Record id
cardio:ct-nct05884866- Content hash
1f7766ba8878209686df00b84ac66cb67e6bf19ab79a5d28dff48dff8f35657d